Research Article| Volume 159, ISSUE 1, P209-212, November 2011

Download started.


Serum estradiol does not differentiate stress, mixed and urge incontinent women around menopause. A report from the Women's Health in the Lund Area (WHILA) study



      To outline serum estradiol levels in perimenopausal women with stress, mixed or urge incontinence. We believe the majority of urgency symptoms in perimenopausal women to be caused by a pelvic floor dysfunction and a hypermobility of the bladder neck. If this is the case, there would be no difference in estradiol levels between the groups.

      Study design

      Setting: University hospital. In the observational Women's Health in the Lund Area study, a subset of 400/2221 women reporting urinary incontinence completed a detailed questionnaire regarding lower urinary tract symptoms and had their serum steroid hormone levels measured. Statistical analyses were made by Chi-square test, nonparametrical tests, ANOVA, multi- and univariate logistic regression analysis.


      Stress incontinence was reported by 196, mixed incontinence by 153 and urge incontinence by 43 women; in 369, serumestradiol values were available. Serum estradiol did not differ significantly between stress incontinent (median 49.5 pmo/l, range 2.63–875.4), urge incontinent (median 31.6 pmol/l, range 2.63–460.7) or mixed incontinent women (median 35.5 pmol/l, range 2.63–787.9, p = 0.62). Logistic regression analysis correcting for age, parity, hormonal status, smoking, hysterectomy and BMI also failed to show any difference in estradiol levels between the groups (p = 0.41–0.58).


      No significant differences in serum estradiol levels between stress, mixed or urge incontinent perimenopausal women could be demonstrated.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • Hextall A.
        Oestrogens and lower urinary tract function.
        Maturitas. 2000; 36: 83-92
        • Diep N.
        • Constantinou C.E.
        Age dependent response to exogenous estrogen on micturition, contractility and cholinergic receptors of the rat bladder.
        Life Sci. 1999; 64: 279-289
        • Van Geelen J.M.
        • Doesburg W.H.
        • Thomas C.M.G.
        Urodynamic studies in the normal menstrual cycle: the relationship between hormonal changes during the menstrual cycle and the urethral pressure profile.
        Am J Obstet Gynecol. 1981; 141: 384-392
        • Salmon U.L.
        • Walter R.I.
        • Gast S.H.
        The use of estrogen in the treatment of dysuria and incontinence in postmenopausal women.
        Am J Obstet Gynecol. 1941; 14: 23-31
        • Moehrer B.
        • Hextall A.
        • Jackson S.
        Oestrogens for urinary incontinence in women.
        Cochrane Database Syst Rev. 2003; 2: CD001405
        • Fantl J.A.
        • Cardozo L.D.
        • McClish D.K.
        Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the Hormones and Urogenital Therapy Committee.
        Obstet Gynecol. 1994; 83: 12-18
        • Fantl J.A.
        • Bump R.C.
        • Robinson D.
        • McClish D.K.
        • Wyman J.F.
        Efficacy of estrogen supplementation in the treatment of urinary incontinence. The Continence Program for Women Research Group.
        Obstet Gynecol. 1996; 88: 745-749
        • Jackson S.
        • Shepherd A.
        • Brookes S.
        • Abrams P.
        The effect of oestrogen supplementation on post-menopausal urinary stress incontinence: a double-blind placebo-controlled trial.
        BRJOG. 1999; 106: 711-718
        • Hendrix S.L.
        • Cochrane B.B.
        • Nygaard I.E.
        • et al.
        Effects of estrogen with and without progestin on urinary incontinence.
        JAMA. 2005; 293: 935-948
        • Grodstein F.
        • Lifford K.
        • Resnick N.M.
        • Curhan G.C.
        Postmenopausal hormone therapy and risk of developing urinary incontinence.
        Obstet Gynecol. 2004; 103: 254-260
        • Waetjen L.E.
        • Feng W.-Y.
        • Ye J.
        • et al.
        Factors associated with worsening and improving urinary incontinence across the menopausal transition.
        Obstet Gynecol. 2008; 111: 667-677
        • Cody J.D.
        • Richardson K.
        • Moehrer B.
        • Hextall A.
        • Glazener C.M.A.
        Oestrogen therapy for urinary incontinence in post-menopausal women.
        Cochrane Database Syst Rev. 2009; (Art. No.: CD001405. doi:10.1002/14651858.CD001405.pub2)
        • Teleman P.
        • Persson J.
        • Mattiasson A.
        • Samsioe G.
        The relation between urinary incontinence and steroid hormone levels in perimenopausal women. A report from the Women's Health in the Lund Area (WHILA) study.
        Acta Obstet Gynecol Scand. 2009; 88: 927-932
        • Samsioe G.
        • Lidfeldt J.
        • Nerbrand C.
        • Nilsson P.
        The Women's Health In the Lund Area (WHILA) study – an overview.
        Maturitas. 2010; 65: 37-45
        • Abrams P.
        • Blaivas J.G.
        • Stanton S.L.
        • Andersen J.T.
        The standardisation of terminology of lower urinary tract function. The International Continence Society Committee on Standardisation of Terminology.
        Scand J Urol Nephrol Suppl. 1988; 114: 5-19
        • Hannestad Y.S.
        • Rortveit G.
        • Sandvik H.
        • Hunskaar S.
        A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT Study.
        J Clin Epidem. 2000; 53: 1150-1157
        • Jackson R.A.
        • Vittinghoff E.
        • Kanaya A.M.
        • et al.
        Urinary incontinence in elderly women: findings from the Health, Aging and Body composition study.
        Obstet Gynecol. 2004; 104: 301-307
        • Grady D.
        • Brown J.
        • Vitinghoff E.
        • Applegate W.
        • Varner E.
        • Snyder T.
        Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study.
        Obstet Gynecol. 2001; 97: 116-120
        • Hunskaar S.
        • Arnold E.P.
        • Burgio K.
        • Diokno A.C.
        • Herzog A.R.
        • Mallett V.T.
        Epidemiology and natural history of urinary incontinence.
        in: Abrams P. Khoury S. Wein A. Incontinence. Health Publication Ltd., Monaco1999: 197-226
        • Hunskaar S.
        • Burgio K.
        • Diokno A.
        • Herzog A.R.
        • Hjälmås K.
        • Lapitain M.C.
        Epidemiology and natural history of urinary incontinence in women.
        Urology. 2003; 62: 16-23
        • Diokno A.C.
        • Brock B.M.
        • Herzog A.R.
        • Bromberg J.
        Medical correlates of urinary incontinence in the elderly.
        Urology. 1990; 36: 129-138
        • Gopal M.
        • Sammel M.D.
        • Arya L.A.
        • Freeman E.W.
        • Lin H.
        • Gracia C.
        Association of change in estradiol to lower urinary tract symptoms during the menopausal transition.
        Obstet Gynecol. 2008; 112: 1045
        • Jackson S.
        • James M.
        • Abrams P.
        The effect of oestradiol on vaginal collagen metabolism in postmenopausal women with genuine stress incontinence.
        BJOG. 2002; 109: 339-344
        • Robinson D.
        • Rainer R.O.
        • Washburn S.A.
        • Clarkson T.B.
        Effects of estrogen and progestin replacement on the urogenital tract of the ovariectomized cynomolgus monkey.
        Neurourol Urodyn. 1996; 15: 215-221
        • Hvidman L.
        • Foldspang A.
        • Mommsen S.
        • Bugge Nielsen J.
        Does urinary incontinence occurrence depend on the menstrual cycle phase?.
        Acta Obstet Gynecol Scand. 2001; 81: 347-350
        • Hvidman L.
        • Foldspang A.
        • Mommsen S.
        • Bugge Nielsen J.
        Menstrual cycle, female hormone use and urinary incontinence in premenopausal women.
        Int Urogynecol J. 2003; 14: 56-61
        • Chen B.
        • Wen Y.
        • Zhang Z.
        • Wang H.
        • Warrington J.A.
        • Polan M.L.
        Menstrual phase-dependent gene expression differences in periurethral vaginal tissue from women with stress incontinence.
        Am J Obstet Gynecol. 2003; 189: 89-97